arrow
A

Alberto Farolfi

irccs istituto romagnolo per lo studio dei tumori irst dino amadori
H指数:28
被引数:2,609

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathologic response and molecular correlates of giredestrant in patients with grade 1 clinical stage IA endometrioid endometrial cancer: the phase II endomERA study

Giredestrant在G1期临床IA期子宫内膜样子宫内膜癌患者中的病理反应及分子相关性:endomERA II期研究

2026-10-130
OA
The TRUST trial in ovarian cancer: a missed opportunity or a turning point? The position of the Italian MITO group

卵巢癌中的TRUST试验:错失的机会还是转折点?意大利MITO小组的观点

2026-05-280
OAAI
Risk of myelodysplastic syndrome and acute myeloid leukemia related to PARP inhibitor maintenance line in real-world ovarian cancer patients

与PARP抑制剂维持治疗线相关的骨髓增生异常综合征和急性髓系白血病的风险,在真实世界卵巢癌患者中的研究

2025-09-010
OAAI
Homologous Recombination Repair Status In Advanced Endometrial Cancer. An Exploratory Biomarker Analysis From The Randomized, Phase II MITO END 3 Trial

高级子宫内膜癌的同源重组修复状态。来自随机、II期MITO END 3试验的探索性生物标志物分析

2025-02-010
PRE
Hormonal Therapy In Endometriosis And Breast Cancer Risk Propensity Score-Matched Real-World Analysis

子宫内膜异位症中的激素疗法与乳腺癌风险倾向评分匹配的真实世界分析

2025-02-010
PRE
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

影响年轻乳腺癌患者5年坚持辅助内分泌治疗的因素

BREAST
IF7.9
2024-10-010
OAAI
Unlocking the potential of Molecular Tumor Boards: from cutting-edge data interpretation to innovative clinical pathways
2024-07-012
OAAI
MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy
2024-07-014
PRE
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
2024-03-014
OAAI
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
2023-08-1117
PRE
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland
2022-06-103
PRE